Comparison of Nebulized Ketamine With Nebulized Magnesium Sulfate for the Prevention of Postoperative Sore Throat

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorSohag University

About this trial

The aim of this study is to compare the efficacy of nebulized ketamine versus nebulized magnesium sulfate in reducing the incidence and severity of POST.

* Primary outcome

• To compare the incidence of POST method. * Secondary outcomes

* Onset, Severity, and duration of POST at 0, 2, 4, 6, 12, 24 hours postoperative. * The hemodynamics recording (HR, BP, MBP, pre and post nebulization) * Adverse Effects (e.g., sedation, cough, nausea, vomiting, ….)

Eligibility criteria

Qualifiers

Age from 18 to 65 years old.

Both sexes.

American Society of Anesthesiologists (ASA) physical status I-II.

Elective surgery requiring GA with endotracheal intubation.

Disqualifiers

Surgery involves the oral cavity, nasopharynx, larynx, and neck regions.

Surgery requires prone position.

Surgery lasted more than 3 hours.

History of preoperative sore throat, common cold.

Trial design

Treatments tested in this trial

  • Ketamine nebulizer
  • Mg sulfate nebulizer
  • Placebo

Treatment groups

150 Participants
are divided into 3 treatment groups

Locations

This trial has no locations

Sponsors and collaborators